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Are there socioeconomic gradients in stage and grade of breast
cancer at diagnosis? Cross sectional analysis of UK cancer registry
data
Jean Adams, Martin White, David Forman
Socioeconomic gradients in uptake of breast cancer screening in
the United Kingdom should, intuitively, lead to socioeconomic
gradients in disease progression at diagnosis.1 However, studies
have found little evidence of such an effect.2–5 Although this
could be interpreted as evidence that socioeconomic gradients in
uptake of screening do not have clinically important conse-
quences, all of the published studies have used data from before
(pre-1988) or during the early stages (1988-95) of implementa-
tion of the national breast cancer screening programme. We
investigated the relation between socioeconomic position and
progression of breast cancer at diagnosis by using recent data
from the Northern and Yorkshire Cancer Registry and Informa-
tion Service (NYCRIS), which is estimated to achieve around
93% ascertainment.
Methods and results
We assessed progression of breast cancer (ICD-10 C50) as both
stage and grade at diagnosis.We defined advanced stage as nodal
or metastatic spread and high grade as poorly differentiated,
undifferentiated, or anaplastic disease. We used Townsend depri-
vation scores of enumeration district of residence at
registration—from 1991 census data standardised to the
Northern and Yorkshire region as a whole—to quantify
socioeconomic position.
All 12 793 women with breast cancer registered with
NYCRIS between 1998 and 2000 were eligible for inclusion. Full
information was available for 11 512 (90.0%) women on stage of
cancer at diagnosis and for 10 388 (81.2%) women on grade of
cancer at diagnosis. The table shows the odds ratios for advanced
stage or high grade of breast cancer at diagnosis by fifths of
Townsend score.
Stage at diagnosis was advanced in 1455 (12.6%) women, and
grade was high in 3176 (30.6%). We found significant trends
according to Townsend score in the likelihood of advanced stage
(2 = 25.52, P < 0.0001) and high grade at diagnosis (2 = 8.34,
P = 0.004); women in the most deprived fifth had odds ratios of
1.53 (95% confidence interval 1.28 to 1.82) for advanced stage
and 1.15 (1.00 to 1.31) for high grade at diagnosis, compared
with those in the most affluent fifth. An age stratified analysis
found that the effect of socioeconomic position on disease pro-
gression at diagnosis was stronger in women potentially exposed
to breast cancer screening than in those not exposed (see
bmj.com for full details). Compared with women in the most
affluent fifth, the odds of women in the most deprived fifth hav-
ing advanced stage at diagnosis was 1.75 (1.38 to 2.22) in those
eligible for screening (aged 50-74 in 1998-2000) and 1.42 (1.22
to 1.65) in those not eligible (aged < 50 or ≥ 75 in 1998-2000).
Odds ratios for high grade at diagnosis were 1.21 (1.02 to 1.43)
and 0.90 (0.76 to 1.05).
Comment
We have found strong socioeconomic trends in the chance of
both advanced stage and high grade of breast cancer at diagno-
sis. Women living in more materially deprived areas tended to
have more advanced disease at diagnosis than those living in less
deprived areas.
Socioeconomic variations in the use of hormone replace-
ment therapy may have confounded our results in relation to
grade at diagnosis. Furthermore, tumour grade may not be an
accurate marker of breast cancer progression. However, the
direction of effect seen here is consistent in terms of both stage
and grade, with a stronger magnitude of effect in relation to
Further information and an extra table are on bmj.com
Odds ratios with tests for trend of odds of advanced stage or high grade of breast cancer at diagnosis by fifths of Townsend deprivation score, adjusted for
age (Northern and Yorkshire region, 1998-2000)
Fifth of TDS TDS range
Advanced stage at diagnosis* High grade at diagnosis†
No (%) Odds ratio (95% CI) No (%) Odds ratio (95% CI)
1 (most affluent) −8.89 to −3.32 247/2349 (10.5) 1.00 635/2139 (29.7) 1.00
2 −3.32 to −1.82 253/2319 (10.9) 1.02 (0.84 to 1.23) 603/2115 (28.5) 0.94 (0.82 to 1.07)
3 −1.82 to 0.07 300/2325 (12.9) 1.19 (0.99 to 1.43) 632/2097 (30.1) 1.01 (0.89 to 1.16)
4 0.07 to 2.59 290/2242 (12.9) 1.20 (1.00 to 1.44) 642/2028 (31.7) 1.10 (0.96 to 1.26)
5 (most deprived) 2.59 to 8.45 365/2277 (16.0) 1.53 (1.28 to 1.82) 664/2009 (33.1) 1.15 (1.00 to 1.31)
Test for trend of odds 2=25.52, P<0.0001 2=8.34, P=0.004
TDS=Townsend deprivation score.
*Defined as nodal or metastatic spread.
†Defined as poorly differentiated, undifferentiated, or anaplastic.
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stage. This is the first work in this area to use data from NYCRIS,
and, although it is unlikely, our results might reflect
geographical, rather than temporal, variations in breast cancer
progression by socioeconomic position.
Clear socioeconomic gradients in the uptake of breast
screening have been reported,1 and breast cancer screening
increases the detection of breast cancers early in their clinical
course. The socioeconomic gradients in disease progression at
diagnosis may thus be due in part to socioeconomic gradients in
uptake of breast cancer screening. The finding that no such gra-
dients were present in data collected before the implementation
of the national breast cancer screening programme supports this
explanation, although such data are from other parts of the
United Kingdom and rarely have complete stage data. Other fac-
tors must explain the gradient in women who were not screened.
The national breast cancer screening programme may have
led to socioeconomic inequalities in disease progression at diag-
nosis in the United Kingdom. Further consideration of the pos-
sible impact of interventions on socioeconomic inequalities in
health is needed.
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What is already known on this topic
Socioeconomic gradients exist in uptake of breast cancer
screening in the United Kingdom
What this study adds
Significant socioeconomic trends exist in the likelihood of
breast cancer being diagnosed at high grade or advanced
stage
These trends are stronger in women potentially exposed to
the breast cancer screening programme
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